Fibromax and inflamatory markers cannot replace liver biopsy in the evaluation of non-alcoholic fatty liver disease.

CONCLUSIONS: The Fibromax™ test and the inflamatory markers (IL 1 beta, IL-6, IL-8, TNF-alpha, MCP-1) did not present a satisfactory performance to be considered a good alternative to replace liver biopsy in the evaluation of NAFLD. PMID: 32700499 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32700499?dopt=Abstract

Source: Minerva Gastroenterologica e Dietologica - July 25, 2020 Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research